Ghent (Belgium), 18 July 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) is excited to highlight the exceptional capabilities of our Research and Development (R&D) team, whose innovative work has brought Olivafix® Gold to the forefront of denture adhesive technology.
Knokke (Belgium), 28 June 2024, 6:00 p.m; bonyf NV (Ticker: MLBON) presents its 2023 financial statements, approved by its Board of Directors and audited by its Statutory Auditors.
Ghent (Belgium), 7 June 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) is proud to reaffirm our commitment to R&D, as well as to highlight the proven effectiveness of our unique fast pain-relief mouth ulcer cream AphtoFix®.
Ghent (Belgium), 10 May 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) is poised for exponential growth in 2024.
Ghent (Belgium), 16 April 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) is thrilled to announce that our company is expanding its clientele in 2024, largely attributed to our successful participation in last year's PLMA exhibition in Amsterdam.
Ghent (Belgium), 2 April 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) is thrilled to announce the progression to Phase 2 in the development of its revolutionary Alginate-Organic Denture Fixative Cream.
Ghent (Belgium), 13 February 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) welcomes you to invest in its shares.
Ghent (Belgium), 11 January 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) has secured key partnerships with an Austria-German multinational and a leading pharma company in Ukraine.
Ghent (Belgium), 22 December 2023, 6:00 a.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, had asked for its shares to be suspended from trading following interest from a strategic investor in acquiring a 30% stake.
Ghent (Belgium), 20 July 2023, 6:00 p.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, presents its 2022 consolidated financial statements, approved by its Board of Directors and audited by its Statutory Auditors
